Reading Time: 4 minutesThis is a guest blog by Kelly Siemund from the University of Leipzig in Germany. I am an early-career researcher in neuroscience, specifically working on
Tag: ALS
Reading Time: 5 minutesWhile we work hard for a cure, it is essential we support those living with MND now. Professor Chris McDermott, Professor of Translational Neurology at
Reading Time: 5 minutesDespite extensive research, the causes of MND remain largely unknown. Recent investigations have begun to shed light on the gut microbiome and whether it may
Reading Time: 4 minutesThis is blog number 5 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green text correspond
Reading Time: 3 minutesThe Science Show on ABC Radio National in Australia, features an interview with Professor Justin Yerbury on Saturday 17th August. The article containing the interview
Reading Time: 4 minutesIn April this year MND clinician-researchers Professors Martin Turner and Kevin Talbot at the University of Oxford organised an information day about the rare, inherited
Reading Time: 5 minutesIt’s been over a month since the announcement by the FDA of their decision to licence edaravone / Radicava for people with MND in the
Reading Time: 4 minutesEach year, the MND Association dedicates the month of June to raising MND awareness. This year, we focus on the eyes – in most people
Reading Time: 2 minutesOn Friday 5 May in America, the FDA, the organisation that approves drugs, announced that they’d granted a licence for the drug known as a